COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03053271
Recruitment Status : Terminated (Slow enrollment)
First Posted : February 15, 2017
Last Update Posted : February 21, 2020
Information provided by (Responsible Party):
Millendo Therapeutics, Inc. ( Millendo Therapeutics US, Inc. )

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 17, 2019
Actual Study Completion Date : August 12, 2019
Certification/Extension First Submitted : October 16, 2019